The Claim
The insulin-to-glucagon ratio directly determines the rate of lipolytic activity in human adipose tissue.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The balance between insulin and glucagon in the blood controls how much fat is broken down in human fat tissue.
See the scientific wording
The insulin-to-glucagon ratio is a primary determinant of lipolytic activity in human adipose tissue.
When insulin levels are high, it binds to fat cells and turns off the enzyme that breaks down fat, preventing fatty acids from being released. When glucagon levels rise, it does not turn on fat breakdown in human fat tissue. The amount of fat released depends on how strongly insulin can block this enzyme, not on glucagon's activity.
What the research says
2 studiesWhen insulin is better at telling fat cells to stop breaking down fat, people lose more weight — even when eating the same diet. This suggests that the balance between insulin and glucagon (which does the opposite) controls how much fat your body burns.
The study found that giving glucagon — a hormone thought to help break down fat — didn’t make fat tissue break down any more in humans. This contradicts the idea that the balance between insulin and glucagon controls fat breakdown.
Related videos
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.